Edwards Lifesciences to Present at the 31st Annual J.P. Morgan Healthcare Conference
(firmenpresse) - IRVINE, CA -- (Marketwire) -- 01/02/13 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco, California on Monday, January 7, 2013.
Michael A. Mussallem, Edwards Lifesciences' chairman and chief executive officer, is scheduled to speak to conference attendees at 4:00 p.m. PST (7:00 p.m. EST). A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at . An archived version of the webcast will be available later that day on the Edwards investor relations website in the News and Events section and via the Edwards Lifesciences Investor Relations App for mobile devices.
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at .
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.
Media Contact:
Sarah Huoh
949-250-5070
Investor Contact:
David K. Erickson
949-250-6826
Edwards Lifesciences Corporation
One Edwards Way
Irvine, CA USA 92614
Phone: 949.250.2500
Fax: 949.250.2525
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.01.2013 - 15:59 Uhr
Sprache: Deutsch
News-ID 1183821
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
IRVINE, CA
Phone:
Kategorie:
Medical Devices
Anmerkungen:
Diese Pressemitteilung wurde bisher 174 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Edwards Lifesciences to Present at the 31st Annual J.P. Morgan Healthcare Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
Edwards Lifesciences (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
